Objective: The objective of this study was to determine the prevalence of hypoglycemia after burn injury and whether hypoglycemia is associated with increased postburn morbidity and mortality. Design: Cohort analysis. Setting: Academic pediatric burn hospital.
Current guidelines for the treatment of critically ill, septic, trauma, and burn patients call for less restrictive glucose ranges of 130-150 mg/dL (4, 8, 9) or 160-180 mg/dL (10) . Finfer et al (11) recently reported that hypoglycemia increases ICU morbidity and mortality.
Despite the realization that hypoglycemic episodes should be avoided, the short-and long-term consequences of hypoglycemic episodes in the critical care setting, or even in the burn care setting, are not entirely clear. More importantly, it is also unclear whether the number of episodes or the duration of the periods of hypoglycemia may increase morbidity and mortality or worsen clinical outcomes. The objective of this study was to determine the prevalence of hypoglycemic episodes after burn injury and to investigate whether hypoglycemia may contribute to morbidity and mortality after burns.
PATIENTS AND METHODS
Seven hundred sixty children who had severe burns (> 30% of the total body surface area, TBSA) and who had to undergo at least one surgical intervention were included in this study. Children were stratified according to the number of hypoglycemic episodes in the following manner: no hypoglycemic episodes (0), one hypoglycemic episode (1), or more than one episode (2+). Patients with a glucose reading less than 60 mg/ dL were considered hypoglycemic. Details are given in the consort diagram (Fig. 1) .
All patients were treated according to standardized clinical protocols for resuscitation (Galveston formula: 5,000 cc/m 2 TBSA burned + 2,000 cc/m 2 TBSA lactated Ringer's solution given in increments over the first 24 hr) and nutrition (1,500 kcal/m 2 body surface + 1,500 kcal/m 2 area burn) (5, (12) (13) (14) (15) . All patients underwent complete wound excision within 2 days of admission. Wounds were covered with autograft, and if necessary, remaining open areas were covered with homograft. Patients underwent grafting procedures until all open wounds were covered with autologous skin.
Demographics (age, date of burn, date of hospitalization, gender, burn size, and depth), injury characteristics (severity of burn and inhalation injury), comorbidities, and clinically relevant variables, such as sepsis, morbidity, and mortality, were recorded. Sepsis was assessed using Society of Critical Care Medicine criteria adjusted for burns. Criteria included a positive blood culture or pathologic tissue identifying the pathogen during hospitalization or at autopsy, with the presence of three or more of the following: leucocytosis or leucopenia (> 12,000 or < 4,000), hyperthermia or hypothermia (> 38.5°C or < 36.5°C), tachycardia (exceeding 20% of the normal heart rate for age), refractory hypotension (systolic blood pressure < 90 mm Hg), thrombocytopenia (platelets < 50,000/mm 3 ), hyperglycemia (serum glucose > 240 mg/dL), and enteral feeding intolerance (residuals > 200 cc/hr or diarrhea > 1 L/d), as previously published (12, 13, 15) . Prevalence of organ failure was determined using the DENVER2 score, which includes renal, hepatic, cardiac, and pulmonary function components. Organ functions were continuously monitored during hospitalization. MOF was defined as a total score more than 2 for two or more organs for at least two consecutive days (16) (17) (18) (19) . The interval between surgeries served as a surrogate marker of wound healing and reepithelialization time.
Patient data were prospectively collected and recorded by staff using Emtek. Data were processed with Microsoft Access or Excel (Redmond, WA).
Glucose Metabolism
For each patient, blood glucose concentrations were assessed on multiple occasions throughout the day. Blood glucose concentrations were quantified using the hexokinase assay ( Siemens Healthcare Diagnostics, West Sacramento, CA). Daily average, minimum, and maximum values were determined for each patient. Insulin doses were recorded when appropriate.
Cytokines and Biomarkers
Blood was collected in serum-separator tubes for clinical routine measurements throughout the entire duration of hospitalization. Serum was isolated by centrifugation at 1,320 rpm for 10 minutes and kept at -70°C until analysis. As already mentioned, glucose concentrations were determined using the hexokinase assay. Serum proteins were quantified using high-performance liquid chromatography, nephelometry (BNII, Plasma Protein Analyzer; Siemens Healthcare Diagnostics), and enzyme-linked immunosorbent assay. Cytokines were analyzed using Bio-Plex Suspension Arrays Patients admitted between (data recorded) 1999 and 2008 n=4047
Acute patients n=3136
Burn area >30%TBSA n=1264
Admitted till day 20 n=1205
At least 5 glucose measurements patients included n=760
Matched patients n=166 per group and the Bio-Plex Human Cytokine 17-Plex panel (Bio-Rad, Hercules, CA).
Cardiac and Pulmonary Function
Heart, lung, kidney, and liver function were assessed using DENVER2 score definitions as described by Moore et al (20) . The cardiac function score was based on the number and dosages of inotrope substances that were administered (Supplemental 
Ethics and Statistics
This study was reviewed and approved by the Institutional Review Board at the University Texas Medical Branch, Galveston, TX. Prior to the study, the subjects, parents, or child's legal guardian agreed to participate in the study by signing an informed consent form. Children under 7 years gave assent to participate. Continuous variables are reported as mean ± sd or sem and categorical variables as frequency and percentage. Patients comprising the full group were compared using t test or Wilcoxon rank-sum test for continuous data and chi-square or Fisher exact test for the categorical data. A logistic regression model for mortality was fitted to compare patients with one, two, and three or more than three hypoglycemic events with those with no hypoglycemic events, adjusting for TBSA, inhalation injury, age, sex, and time from burn to admission. The Hosmer-Lemeshow test was used to assess the fit of the model. The propensity score model included the following available baseline characteristics: age, inhalation injury, total percent TBSA burned, percent TBSA with third-degree burns, time from burn to admission, sex, and type of burn. Patients were matched 1:1 based on the logit of the propensity scores using a greedy matching procedure with calipers 0.2 of the sd of the logit of propensity score. Standardized differences were calculated to check for balance in the matched characteristics. Clinical outcomes for the propensity-matched patients were compared using paired t test or Wilcoxon signed-rank test and McNemar test.
The log-rank test was used to compare survival curves in unmatched patients. In matched patients, a Cox model was used by taking the clustering into consideration and using a robust sandwich estimator for the variance. We performed a sensitivity analysis Cox proportional-hazards model for time from burn to death with time-dependent covariates: time to hypoglycemia and time to cardiac, liver, kidney, and lung failure for a subset of 748 patients for whom these data were available. For this analysis, patients were censored at discharge. This analysis should be interpreted with caution as the time-dependent hypoglycemia is related to subject's health status (21) . Data were analyzed with SAS 9.2 (SAS Institute, Cary, NC), and p value of less than 0.05 was considered significant. Patients included in this study are part of a clinical trial registered at http://www.clinicaltrials.gov (#NCT00673309).
RESULTS

Demographics and Outcome for the Whole Patient Population
Characteristics and outcomes for the entire patient population are presented in Table 1 . Five hundred sixty-eight patients never became hypoglycemic (control/0), whereas 192 patients had hypoglycemic episodes. Of these 192 patients, 84 had one (1) and 108 had more than one episode (2+) throughout acute hospitalization (up to 60 d). Patients in both groups had similar sex and ethnicity distribution. Patients had no preexisting comorbidities. The majority of patients experiencing hypoglycemic episodes sustained flame burns (p < 0.001). Patients with hypoglycemic episodes had a significantly greater burn size (control, 51% ± 16% TBSA burned vs hypoglycemia, 66% ± 18% TBSA burned; p < 0.001), third-degree component (control, 32 ± 24; hypoglycemia, 55 ± 27; p < 0.001), and prevalence of inhalation injury (control, 163 [29%]; hypoglycemia, 102 [53%]; p < 0.0001). More patients from the hypoglycemic groups than those from the control group made up the intensive insulin therapy group of the prospective randomized trial (5) (control, 9 [2%] vs hypoglycemia, 32 [17%]; p < 0.001).
Clinical outcomes (Table 1) differed by cohort; compared with control patients, both patient groups with hypoglycemic episodes had more operating room visits, longer stays in the ICU (even when normalized for burn size), higher mortality rates, higher prevalence of MOF, greater maximum DENVER2 scores, and more septic and infectious episodes (p < 0.05). Feeding intolerance was comparable between groups.
Probability of survival for the first 100 days after burn was determined by the Kaplan-Meier method ( Fig. 2A) . Differences were found among the three groups (log-rank test, p ≤ 0.0001), with progressively higher mortality being found in patients with one hypoglycemic episode and than in patients with two or more hypoglycemic episodes. The odds of dying increased as the number of hypoglycemic events increased ( Table 2 ) ( compared with no hypoglycemic event: 1 event odds ratio = 2.67; 95% CI, 1.15-6.20; two events odds ratio = 5.58; 95% CI, 2.26-13.81). Burn size and being female were also associated with greater odds of dying. Similar results were obtained using the survival analysis model for burn to death, with hypoglycemia as time-dependent covariate being associated with a larger hazard of dying ( Table 3) .
Another logistic regression analysis included the variables of burn size (percent TBSA burned), third-degree burn size, and intensive insulin therapy. A positive correlation existed between the number of hypoglycemic episodes throughout the hospital stay and insulin administration (data not shown, p = 0.002).
Prevalence of Hypoglycemic Episodes
The prevalence of hypoglycemic episodes in the total patient population peaked approximately 12 days after burn injury and then decreased steadily until the last studied time point, as depicted by the trend line in Figure 3A . Sizes of the circles indicate the percentage of measurements from all patients that fell below 60 mg/dL on the day in question. 
Demographics and Outcomes for Matched Patient Cohorts
Using a propensity score model, we matched 166 controls with 166 hypoglycemic pediatric patients ( Table 4 ). Patients matched for injury according to the aforementioned criteria had an average burn size of 63% TBSA with an average third-degree component of 50%. The groups had comparable prevalence of inhalation injury (control, 49% vs hypoglycemia, 48%), age (control, 8.3 ± 5.4 yr vs hypoglycemia, 7.6 ± 5.6 yr), and sex distribution. Significant differences in these characteristics were not detected in the matched group, although this group exhibited a standardized difference of slightly larger than 10% (nonclinically important difference) for age.
The probability of being administered intensive insulin therapy was higher in the hypoglycemic group (control, 2% vs hypoglycemia, 19%; p < 0.001). Clinical outcome variables were poorer in the hypoglycemic group. Hypoglycemic patients underwent significantly more surgeries (control, 4 [2-6] vs hypoglycemia, 5 [3] [4] [5] [6] [7] ; p < 0.0018). The total length of the ICU stay was similar in the two groups (control, 30 d vs hypoglycemia, 32 d; p = 0.074). Similarly, length of stay normalized for burn size did not differ between groups (p = 0.058). Hypoglycemic patients had significantly higher overall mortality (p = 0.0002) and prevalence of clinical complications such as MOF (p < 0.0001), combined with higher maximum DENVER2 scores (p < 0.0001) and prevalence of sepsis (p = 0.02). The infection rate did not significantly differ between the groups.
Time to death was significantly different as seen by the Kaplan-Meier curve in Figure 2B and the Cox proportional-hazards model accounting for matched patients (p = 0.0002).
Glucose Metabolism and Insulin Requirements
Patients with hypoglycemic episodes received significantly more units of insulin throughout the hospital course (p < 0.05) ( Fig. 3B) . Daily average glucose values were highly similar in both groups (Fig. 3C) , but the hypoglycemic group had higher daily maximum values (p < 0.05) as well as lower minimum values after the first week postburn (Fig. 3D) .
Inflammatory Variables
The cytokines interleukin (IL)-1β, IL-6, IL-8, and monocyte chemotactic protein (MCP)-1 were significantly higher in the hypoglycemic group ( Fig. 4 A-D) (p < 0.05). IL-1β, IL-6, and MCP-1 underwent immediate increases, whereas IL-8 increased around day 11. The established inflammatory marker, C-reactive protein (CRP) (Fig. 4E) , did not show any clear pattern of differences between the groups at any time, with one exception. At the 35-to 40-day time point, CRP levels were significantly higher in the hypoglycemic group (p < 0.05). Levels of retinol-binding protein (RBP) significantly differed between the groups at the first three time points until day 10 although no uniform pattern was noted ( Fig. 4F) (p < 0.05). RBP levels increased at a similar rate between the groups until the end of the study period.
Free Fatty Acids and Proteins
Free fatty acid levels dropped immediately after day 1 in both groups (Fig. 5A) . Control patients had significantly higher plasma levels from after day 10 until day 34 (p < 0.05). Apolipoprotein A1 followed a similar pattern, with significantly higher levels being seen from day 2 until day 40 (p < 0.05) ( Fig. 5B) . 
Metabolic and Organ Function Markers
The hypoglycemic group had significantly impaired liver function, as assessed by bilirubin, and kidney function, as assessed by blood urea nitrogen (BUN) (Fig. 5, C and D) . The hypoglycemic group exhibited elevated bilirubin levels after the first week postadmission (p < 0.05) and BUN levels immediately after 1 day postadmission (p < 0.05). Respiratory function (Fig. 5E) represented by the Pao 2 /Fio 2 ratio and cardiac function ( Fig. 5F) , which were assessed according to the DENVER2 definitions, did not differ between groups.
DISCUSSION
Tight euglycemic control (1, 2) has changed modern ICU practice (3, 9) . However, multiple studies have recently found that tight glycemic control may contribute to morbidity and mortality, making it unclear if tight glycemic control is indeed beneficial to patients (6, 7, 11) . Several investigators have hypothesized that the increased adverse events seen with intensive insulin therapy and/or tight glycemic control are related to increased hypoglycemic episodes (6, 7, 11) . Although hypoglycemia is known to be a serious adverse event with the potential for severe detrimental outcomes (22), essentially nothing is known regarding the effects of hypoglycemia on outcomes in critical care or burn patients. The Normoglycaemia in Intensive Care Evaluation & Survival Using Glucose Algorithm Regulation investigators (11), therefore, reexamined their data and found that hypoglycemia adversely affects morbidity and mortality in critical care patients. Because the effect of hypoglycemia in burns remains unknown, we investigated whether hypoglycemia (i.e., blood glucose < 60 mg/dL) is associated with adverse effects in pediatric burn patients. We found that in pediatric burn patients, hypoglycemia is associated with a significant increase in death and complications. It was interesting that the prevalence of hypoglycemia was significantly increased in patients who were administered intensive insulin as part of a randomized controlled trial (5) confirming the risk of tight euglycemic control that has since been shown in other trials of glycemic control (5-7, 11, 22-24). Hypoglycemia usually occurs in patients with diabetes, with endocrine tumors, or who are taking drugs that induce; the prevalence of hypoglycemia has been reported to be 0.2-0.4% (25) . Episodes of hypoglycemia in the critical care setting have recently gained attention because of the initiation of tight glycemic control (6, 7) . Insulin administration targeting glucose at 80-110 mg/dL results in better outcomes for seriously ill adults and children (1, 2, 24) but leads to an increased prevalence of mild and severe hypoglycemia. A recent prospective randomized trial by our group showed that intensive insulin therapy in pediatric burn patients significantly reduces the occurrence of infections and sepsis, an effect that is accompanied by diminished burn-induced acute-phase and inflammatory responses (5) . In addition, we found that intensive insulin improves kidney and liver function. In burn patients, insulin administration provides improvements in muscle protein anabolism, lean mass, hypermetabolism, wound healing time (26) (27) (28) (29) , and the inflammatory and acute-phase responses (30) (31) (32) (33) . Others have shown that insulin administration post burn decreases infection and sepsis and increases survival (34, 35) . Therefore, there is an important role for insulin administration during the acute-phase postburn, although strict glycemic control using insulin is a double-edged sword as seen by this study. That is, the profound and significant benefits of tight glycemic control come with a danger of hypoglycemia and associated adverse events. The recent guidelines for glucose control established by the American College of 
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Physicians have set 140 mg/dL as the absolute minimum target for intensive insulin therapy to retain the positive effects of tight glycemic control and lessen the chance of hypoglycemia in surgical ICU and medical ICU patients.
Van den Berghe et al (1, 2) have reported an approximate 5% prevalence of hypoglycemia in critically ill patients, whereas other trials have report prevalence in range of 10-25% (6, 7, 24) . Here, we found that hypoglycemia was more frequent in burn patients (26%) than in other patient populations. We believe that multiple reasons exist for increased hypoglycemia. It could be due to the nature of the injury, difficulty in maintaining tight glycemic ranges because of feeding interruption, or variability in feeds. It could be due to interruptions in enteral nutrition for surgery and daily dressing changes, which negatively affect gastrointestinal motility and make adjustments difficult (8, 15, 31) . It may also be that the caloric delivery was inadequate to meet the demand, exacerbating hypoglycemia. Finally, Mann et al (36) and Pidcoke et al (37) have shown that blood glucose measurements in burn patients can be read incorrectly because of existing anemia. Almost all burn patients are anemic, making blood glucose readings in this population potentially inaccurate (36, 37) . This report demonstrates that hypoglycemia is associated with greater death and complications after burn injury. One can only speculate why hypoglycemia is detrimental for burn patients. The CNS uses glucose as its primary source of fuel for energy production (38) . However, endogenous glucose reserves in the CNS last for only minutes, causing cellular energy production to rely heavily on adequate glucose delivery via the blood because neurons cannot generate glucose or use any other energy source (e.g., lipids or proteins). Maintaining an adequate glucose range between 60 and 140 mg/dL is one of the central tasks of the body's metabolism. If blood glucose drops below 60 mg/dL, the body responds by releasing counteracting hormones (e.g., glucagon and epinephrine), as well as by inhibiting insulin release in an attempt to increase blood glucose. However, if hypoglycemia persists, cell damage occurs. One characteristic of burn injury is the large hypermetabolic response, which requires glucose as an energy source. If glucose is not accessible, proteins and lipids are used to fulfill the required metabolic demand, but these stores are depleted in the first 2-3 weeks postburn (39) (40) (41) (42) . Hence, there are no real energy stores for burn patients, and it seems likely that hypoglycemia is more pronounced and more dangerous in burn patients simply because of the heightened need for glucose. The hypothesized increased inflammatory (15) and hypermetabolic responses were confirmed through analysis of cytokines and acute-phase proteins. We found that patients who have at least one episode of hypoglycemia have a greater inflammatory response and express significantly higher acute-phase proteins than patients who never experienced hypoglycemia. This could be an interesting link between low glucose and hyperinflammation, because enhanced inflammation drives higher metabolic need, increasing the turnover and hence increasing the risk for hypoglycemia. Increased hypermetabolism and turnover subsequently leads to impaired organ function, suppression of the immune system, and ultimately death.
In infants, hypoglycemia may develop because of limited glycogen reserves. For this reason, fluid administration in children often involves 5% dextrose with Ringer's lactate. Thus, hypoglycemia in pediatric burn patients acutely may be caused by the method of fluid infusion. The practice in our hospital is to avoid giving IV glucose. Rather, the patient is fed as soon as possible after admission with a regular diet, via nasojejunal or nasogastric feeding tube, using Vivonex T.E.N. (Nestle, Florham Park, NJ), which is very high glucose nutrition, and we, therefore, suggest that hypoglycemia is not due to failure of glucose delivery.
A central focus of this study was whether hypoglycemia increases postburn morbidity and mortality or whether hypoglycemia is reflective of sicker patients who are predisposed to morbidity and mortality because of their more severe illness. Our data show that hypoglycemia is the factor leading to detrimental outcomes and not an indicator of sicker patients. Specifically, both the propensity-matched analysis and the logistic regression analysis showed worse outcomes for patients suffering at least one episode hypoglycemia compared with controls with similar burn sizes and injuries. We also noted that hypoglycemia occurred before MOF or infection. As shown in Figure 2 , the majority of hypoglycemia occurred during the early stages after injury, whereas MOF, infection, sepsis, and death occurred at later times. This indicates a causal association and that hypoglycemia leads to increased postburn morbidity and mortality. This finding is of importance because it implies that burn physicians should avoid driving patients into hypoglycemia early after burn. Strategies to avoid hypoglycemia should include safe protocols, constant feeding, and the use of less restricted glucose target ranges. VISEP interventional trial (Prospective randomized multicenter study on the influence of colloid vs crystalloid volume resuscitation and of intensive vs conventional insulin therapy on outcome in patients with severe sepsis and septic shock) and Finney et al (3) propose targeting blood glucose levels to 140 mg/dL and below (6) ; the Amercian College of Physicians recommends a minimum of 140 mg/dL. Despite the controversy regarding the safest lower limit, it is clear that further examination of the issue is necessary. Based on their review of recent glucose modulation studies, Preiser and Devos (4) recommended an intermediate glucose level of 140 mg/dL considering the risk of hypoglycemia associated with intensive insulin administration and uncertainty about the ideal glucose level. In the new surviving sepsis campaign guidelines, Dellinger et al (10) acknowledge that an ideal range to be targeted is unclear and the negative consequences of hypoglycemic episodes, and they advocate use of 180 mg/dL. Investigators from the NICE trial propose targeting levels to 140-150 mg/dL to avoid hyperglycemia and hypoglycemia. Our group previously conducted a trial aimed at identifying morning glucose levels associated with a better survival and fewer complications in the severely burned. An analysis of 300,000 glucose values revealed that patients with levels of 130 mg/dL for the greater part (75%) of their acute hospital stay have better outcomes than patients with glucose levels more than 140 mg/dL (8) . In this study, the ideal glucose range was around 130-140 mg/dL. The glucose curve was U-shaped, indicating that very low and very high glucose levels are equally harmful. A glucose range of 130-150 mg/dL does not seem to induce protein glycosylation and increase risk of severe hypoglycemia. This recommended range is consistent with three studies focusing on pediatric patients and showing similar glucose cutoff values as presented here (43) (44) (45) .
One limitation of this study is that this trial was never set up to prospectively determine the prevalence of hypoglycemia on postburn outcomes, and therefore, all results are based on statistical models. These results are associations, which are difficult to causally link. The propensity score analysis allowed for matching the patients to balance the measured confounders, but it does not take into account any unmeasured confounders. Because of the design of our analysis and what we had available, we may have not included all confounders. Nevertheless, based on our results, we suggest that hypoglycemia adversely affects postburn morbidity and mortality and should be avoided.
CONCLUSIONS
One or more episodes of hypoglycemia are associated with adverse clinical outcomes in severely burned children. However, because glycemic control does improve outcomes in this population, use of management strategies that minimize iatrogenic hypoglycemia is imperative. Consistent, validated approaches should be considered for this purpose.
